Questioning thrombolytic use for cerebrovascular accidents

Journal of Emergency Medicine

Volumn 16, Issue 5, 1998, Pages 757-758

  Li, James ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MOUNT AUBURN HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DRUG EFFECT; FIBRINOLYTIC THERAPY; HUMAN; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0032169535     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-4679(98)00078-X     Document Type: Note

References (15)

1. 1. The National Institute of Neurologic Disorders and Stroke rt-PA Stroke Study Group. Tissue Plasminogen Activator for Acute Ischemic Stroke. N Engl J Med. 1995;333:1581-7.
2. 2. Genentech Investor Relations. Quarterly News - Second Quarter 1997, Marketed Product News, 1997.
3. 3. The European Cooperative Acute Stroke Study (ECASS). Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA. 1995;274:1017-25.
4. 4. Multicentre Acute Stroke Trial - Italy (MAST-I) Group. Randomized controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet. 1995;346: 1509-14.
5. 5. The Multicenter Acute Stroke Trial - Europe Study Group. Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med. 1996;335:145-50.
6. 6. Australian Streptokinase Trial Study Group. Streptokinase for acute ischemic stroke with relationship to time of administration. JAMA. 1996;276:961-6.
7. 7. Frankel MR, Clark WM, Lyden PD, et al. Thrombolytic therapy in acute ischemic stroke - correspondence. N Engl J Med. 1997;336: 65.
8. 8. Bukata WR. Thrombolytic therapy for strokes. Emergency Medicine Abstracts Essay. 1996;20(11).
9. 9. Wilkes G. Thrombolytics and CVA. Emed-1 (UCSF-sponsored internet discussion group) Dec 6, 1996.
10. 10. Alteplase for thrombolysis in acute ischemic stroke. Med Lett. 1996;38:99-100.
11. 11. Louzon H, Siegelson HJ. Thrombolytics and CVA. Emed-1 (UCSF-sponsored internet discussion group) Dec 8, 1996.
12. 12. Hoffman JR. Thrombolytics for CVA. Emed-1 (UCSF-sponsored internet discussion group) Dec 11, 1996.
13. 13. Vadeboncoeur A. Brain attack and t-PA. Emed-1 (UCSF-sponsored internet discussion group) Sept 22, 1997.
14. 14. Genentech. Activase prescribing information (package insert).
15. 15. Koroshetz WJ. Tissue plasminogen activator for acute ischemic stroke - Correspondence. N Engl J Med. 1996;334:1405.